Life Science Pharmacy Inc.
FDA inspection history across 2 sites, 2019 to 2021
- 2
- Responses
- 1
- Untitled letter
- 1
- Form 483
Every document, by year
- Response
- Untitled letter
- Form 483
2019: one 483 response and one Form 483; 2020: one untitled letter; 2021: one untitled letter response.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–21One 483 response, one Form 483, one untitled letter and one untitled letter response, at New York and Harriman, New York.
Cited most
Across all Life Science Pharmacy observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.42Design and construction features2
The complete Life Science Pharmacy file.
All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
New York
One untitled letter response, one untitled letter and one 483 response · 2019 to 2021
Latest: Response, Jan 8, 2021 →Harriman, New York
One Form 483 · 2019 · 5 observations
Latest: Form 483, Nov 20, 2019 →
Documents
4 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-01-08 | Response Untitled letter response | New York | — | $199 |
| 2020-12-09 | Untitled letter Untitled letter | New York | — | $99 |
| 2019-12-11 | Response 483 response | New York | — | $199 |
| 2019-11-20 | 483 Form 483 | Harriman, New York | 5 | $99 |
Investigators on these documents
FEI number 3006997792 · most recent document Jan 8, 2021
About Life Science Pharmacy Inc.
How many FDA Form 483s has Life Science Pharmacy Inc. received?
FDA Intel has 1 Form 483 on file for Life Science Pharmacy Inc.; the most recent is dated Nov 20, 2019.
When was Life Science Pharmacy Inc. last inspected by FDA?
The most recent FDA inspection document on file for Life Science Pharmacy Inc. is a Form 483 dated Nov 20, 2019, for the site in Harriman, New York.
What did FDA cite at Life Science Pharmacy Inc.?
The regulations cited most in the observations on file for Life Science Pharmacy Inc. are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.42 (Design and construction features), 2 times.
Has Life Science Pharmacy Inc. received an FDA untitled letter?
Yes. FDA Intel has 1 FDA untitled letter on file for Life Science Pharmacy Inc.; the most recent is dated Dec 9, 2020. An untitled letter is FDA's enforcement letter for violations that don't rise to warning-letter level.